Aerovate Therapeutics, Inc. [AVTE]

Source: 

Company Overview

Aerovate Therapeutics, Inc. is a biopharmaceutical company. Our initial focus was on advancing AV 101, our dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, or PAH, a devastating disease impacting approximately 70,000 people in the United States and Europe.